Howard University https://www.howard.edu and Johns Hopkins https://www.jhu.edu are teaming up to develop new medical devices to diagnose, treat, and manage neurological disorders.
More than 1 billion people worldwide suffer from neurological disorders which range from Alzheimer’s and Parkinson’s disease to chronic pain, addiction, mental health, multiple sclerosis, stroke, migraines, brain and nerve injuries, and more.
The partnership’s new NeuroTech Harbor (NTH) https://neurotechharbor.org technology is supported by a $5 million investment over 5 years by NIH. NTH is a biotechnology incubator which aims to accelerate the development of cutting edge medical devices to diagnose and treat nervous system disorders.
NIH selected NTH as one of two incubator hubs to foster innovative medical products, and prepare them for first-in-human demonstrations
Experts at the new NTH technology accelerator will partner with teams of top innovators worldwide to supercharge the development of medical devices that improve diagnosis, treatment, and management of neurological disorders while also making these technologies accessible to all communities.
NTH will connect innovators to engineers and specialists with deep and broad biomedical engineering and commercialization expertise by leveraging access to state of the art facilities like the Johns Hopkins University’s Applied Physics Laboratory as well as NTH’s established global networks of angel investors and venture capitalists.
NTH’s consultant network of world-renowned neurotech experts representing diverse backgrounds and experiences includes clinicians, scientists, technologists, commercialization experts, and patient advocates.